$5.16 Billion is the total value of Hillhouse Capital Management's 53 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 61.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JD | Sell | JD COM INCspon adr cl a | $2,454,563,000 | -0.5% | 78,899,475 | -18.6% | 47.60% | -13.5% |
| PCLN | Buy | PRICELINE GRP INC | $452,169,000 | +64.5% | 254,032 | +35.5% | 8.77% | +43.0% |
| MDLZ | Sell | MONDELEZ INTL INCcl a | $381,344,000 | -3.3% | 8,851,996 | -0.5% | 7.40% | -16.0% |
| ESGR | ENSTAR GROUP LIMITED | $334,817,000 | -3.2% | 1,750,218 | 0.0% | 6.49% | -15.9% | |
| WUBA | 58 COM INCspon adr rep a | $196,430,000 | +26.4% | 5,550,451 | 0.0% | 3.81% | +9.9% | |
| MLCO | Buy | MELCO CROWN ENTMT LTDadr | $190,011,000 | +63.5% | 10,248,715 | +40.2% | 3.68% | +42.2% |
| BIDU | Sell | BAIDU INCspon adr rep a | $160,971,000 | -20.6% | 933,057 | -24.3% | 3.12% | -31.0% |
| SINA | SINA CORPord | $102,425,000 | +18.6% | 1,420,208 | 0.0% | 1.99% | +3.1% | |
| CTRP | Buy | CTRIP COM INTL LTD | $98,300,000 | +24.9% | 2,000,000 | +1.6% | 1.91% | +8.5% |
| MOMO | Buy | MOMO INCadr | $89,572,000 | +135.5% | 2,629,062 | +27.0% | 1.74% | +104.6% |
| SOHU | SOHU COM INC | $64,923,000 | +16.1% | 1,650,727 | 0.0% | 1.26% | +0.9% | |
| TAL | TAL ED GROUP | $63,827,000 | +51.9% | 598,920 | 0.0% | 1.24% | +32.1% | |
| TRIP | New | TRIPADVISOR INC | $60,168,000 | – | 1,394,066 | +100.0% | 1.17% | – |
| YUMC | New | YUM CHINA HLDGS INC | $60,149,000 | – | 2,211,372 | +100.0% | 1.17% | – |
| BGNE | BEIGENE LTDsponsored adr | $49,966,000 | +20.6% | 1,364,820 | 0.0% | 0.97% | +4.9% | |
| FB | New | FACEBOOK INCcl a | $41,323,000 | – | 290,908 | +100.0% | 0.80% | – |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $29,322,000 | +116.7% | 733,245 | +52.0% | 0.57% | +88.4% |
| WBMD | WEBMD HEALTH CORP | $29,222,000 | +6.3% | 554,717 | 0.0% | 0.57% | -7.5% | |
| CBPO | New | CHINA BIOLOGIC PRODS INC | $26,309,000 | – | 262,750 | +100.0% | 0.51% | – |
| FGEN | FIBROGEN INC | $24,650,000 | +15.2% | 1,000,000 | 0.0% | 0.48% | +0.2% | |
| XLRN | Buy | ACCELERON PHARMA INC | $18,529,000 | +45.2% | 700,000 | +40.0% | 0.36% | +26.0% |
| ITCI | INTRA CELLULAR THERAPIES INC | $16,250,000 | +7.7% | 1,000,000 | 0.0% | 0.32% | -6.5% | |
| YY | New | YY INC | $15,832,000 | – | 343,357 | +100.0% | 0.31% | – |
| CHTR | New | CHARTER COMMUNICATIONS INC Ncl a | $13,262,000 | – | 40,517 | +100.0% | 0.26% | – |
| LN | LINE CORPsponsored adr | $12,953,000 | +13.1% | 336,800 | 0.0% | 0.25% | -2.0% | |
| SCHW | New | SCHWAB CHARLES CORP NEW | $11,708,000 | – | 286,882 | +100.0% | 0.23% | – |
| CCJ | CAMECO CORP | $11,354,000 | +5.7% | 1,025,700 | 0.0% | 0.22% | -8.3% | |
| TBPH | THERAVANCE BIOPHARMA INC | $11,203,000 | +15.5% | 304,256 | 0.0% | 0.22% | +0.5% | |
| AMZN | New | AMAZON COM INC | $10,250,000 | – | 11,562 | +100.0% | 0.20% | – |
| BRKA | New | BERKSHIRE HATHAWAY INC DELcl a | $9,994,000 | – | 40 | +100.0% | 0.19% | – |
| VRSN | New | VERISIGN INC | $9,160,000 | – | 105,154 | +100.0% | 0.18% | – |
| LBTYK | New | LIBERTY GLOBAL PLC | $8,714,000 | – | 248,697 | +100.0% | 0.17% | – |
| NBRV | Sell | NABRIVA THERAPEUTICS AGsponsored adr | $8,236,000 | +97.7% | 686,900 | -1.9% | 0.16% | +72.0% |
| V | New | VISA INC | $8,185,000 | – | 92,100 | +100.0% | 0.16% | – |
| MCO | New | MOODYS CORP | $8,061,000 | – | 71,949 | +100.0% | 0.16% | – |
| SPGI | New | S&P GLOBAL INC | $7,607,000 | – | 58,187 | +100.0% | 0.15% | – |
| TIG | TIGENIXsponsored ads | $7,548,000 | +7.0% | 483,870 | 0.0% | 0.15% | -7.0% | |
| CLSD | Buy | CLEARSIDE BIOMEDICAL INC | $6,788,000 | +26.5% | 854,900 | +42.5% | 0.13% | +10.0% |
| PTI | PROTEOSTASIS THERAPEUTICS IN | $6,772,000 | -36.2% | 865,923 | 0.0% | 0.13% | -44.7% | |
| ADAP | New | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $6,560,000 | – | 1,190,476 | +100.0% | 0.13% | – |
| ACIU | AC IMMUNE SA | $5,698,000 | -20.2% | 550,000 | 0.0% | 0.11% | -30.8% | |
| SFUN | FANG HLDGS LTDadr | $4,890,000 | -0.6% | 1,500,000 | 0.0% | 0.10% | -13.6% | |
| IDXX | New | IDEXX LABS INC | $4,457,000 | – | 28,825 | +100.0% | 0.09% | – |
| PRTA | PROTHENA CORP PLC | $4,184,000 | +13.4% | 75,000 | 0.0% | 0.08% | -1.2% | |
| MRTX | New | MIRATI THERAPEUTICS INC | $3,770,000 | – | 725,000 | +100.0% | 0.07% | – |
| JNCE | New | JOUNCE THERAPEUTICS INC | $3,745,000 | – | 170,300 | +100.0% | 0.07% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $3,368,000 | – | 245,449 | +100.0% | 0.06% | – |
| PYPL | PAYPAL HLDGS INC | $3,235,000 | +9.0% | 75,186 | 0.0% | 0.06% | -4.5% | |
| XNET | XUNLEI LTDsponsored adr | $1,632,000 | +4.9% | 403,041 | 0.0% | 0.03% | -8.6% | |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $999,000 | +22.9% | 9,262 | 0.0% | 0.02% | +5.6% | |
| LC | LENDINGCLUB CORP | $549,000 | +4.6% | 100,000 | 0.0% | 0.01% | -8.3% | |
| TWTR | New | TWITTER INC | $567,000 | – | 37,900 | +100.0% | 0.01% | – |
| MCRB | SERES THERAPEUTICS INC | $238,000 | +13.9% | 21,093 | 0.0% | 0.01% | 0.0% | |
| ZTO | Exit | ZTO EXPRESS CAYMAN INCsponsored adr | $0 | – | -1,000,462 | -100.0% | -0.27% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MONDELEZ INTL INC | 22 | Q3 2018 | 44.4% |
| JD COM INC | 19 | Q2 2019 | 80.2% |
| SOHU COM INC | 19 | Q1 2018 | 13.4% |
| 58 COM INC | 18 | Q3 2018 | 7.8% |
| TAL EDUCATION GROUP | 18 | Q2 2019 | 4.4% |
| CTRIP COM INTL LTD | 17 | Q2 2017 | 28.4% |
| BEIGENE LTD | 14 | Q2 2019 | 25.2% |
| MELCO RESORT ENTERTAINMENT L | 14 | Q3 2018 | 6.4% |
| CAMECO CORP | 14 | Q4 2017 | 2.2% |
| ENSTAR GROUP LIMITED | 12 | Q2 2019 | 21.9% |
View Hillhouse Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| China Jo-Jo Drugstores Holdings, Inc. | February 14, 2023 | 403,334 | 4.7% |
| TScan Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Enfusion, Inc. | February 14, 2022 | 4,975,183 | 7.6% |
| Enstar Group LTD | July 19, 2021 | ? | ? |
| Zoom Video Communications, Inc. | February 16, 2021 | 2,981,265 | 1.5% |
| NIO Inc. | February 14, 2020 | ? | ? |
| Sea Ltd | February 14, 2020 | 4,300,000 | 2.3% |
| Uxin Ltd | February 14, 2020 | 21,733,023 | 2.6% |
| Apellis Pharmaceuticals, Inc. | February 14, 2019 | 2,098,581 | 3.7% |
| iQIYI, Inc. | February 14, 2019 | 240,191,174 | 11.0% |
View Hillhouse Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-03-05 |
| 13F-NT | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 4 | 2024-02-01 |
| 3 | 2024-01-25 |
| 13F-NT | 2023-11-14 |
| 13F-NT | 2023-08-14 |
View Hillhouse Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.